May 2025
1. MACLEAN B, Fuller J, Lim J, Dugan C, et al
   Greater prevalence of anaemia and heavy menstrual bleeding reported in women of reproductive age in the United Kingdom compared to Australia.
   Br J Haematol. 2025;206:1479-1484.
   

   >> Share

   
   
2. DELICOU S, Manganas K, Diamantidis MD, Venou TM, et al
   Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12-year study.
   Br J Haematol. 2025;206:1466-1478.
   

   >> Share

   
   
3. PRINCE EJ, Scott JL, Nwankwoala O, Ali-Houchens L, et al
   A young adult clinic to support integration into adult sickle cell disease care: If you build it, they will come.
   Br J Haematol. 2025;206:1458-1465.
   

   >> Share

   
   April 2025
4. HOVING V, Donker AE, Schols SEM, Swinkels DW, et al
   How I treat iron-refractory iron deficiency anaemia-An expert opinion-based treatment guidance for children and adults.
   Br J Haematol. 2025;206:1067-1076.
   

   >> Share

   
   
5. METAFUNI E, Brioschi FA, Patriarca A, Leoni C, et al
   Real-world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.
   Br J Haematol. 2025;206:1246-1249.
   

   >> Share

   
   
6. CORSIA A, Joseph L, Beeker N, Manceau S, et al
   Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France.
   Br J Haematol. 2025;206:1218-1227.
   

   >> Share

   
   
7. ENACHE A, Carty SA, Babushok DV
   Origins of T-cell-mediated autoimmunity in acquired aplastic anaemia.
   Br J Haematol. 2025;206:1035-1053.
   

   >> Share

   
   
8. SINHA U, Setty S, Pilon C, Brown JJ, et al
   Systemic lupus erythematosus-associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice.
   Br J Haematol. 2025;206:1213-1217.
   

   >> Share

   
   March 2025
9. DE LIGT LA, Gaartman AE, Konte K, Thakoerdin S, et al
   Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease.
   Br J Haematol. 2025;206:954-964.
   

   >> Share

   
   
10. SCHECHTER AN
    Sickle cell anaemia therapy in 2025.
    Br J Haematol. 2025;206:842-845.
    

    >> Share

    
    
11. LONGORIA JN, Howell KE, Porter JS, Treadwell M, et al
    Depression, sleep and pain affect instrumental activities of daily living through cognitive functioning in adults with sickle cell disease: A report from the Sickle Cell Disease Implementation Consortium.
    Br J Haematol. 2025;206:944-953.
    

    >> Share

    
    
12. LI H, Sachdev V, Tian X, Nguyen ML, et al
    A machine learning-based workflow for predicting transplant outcomes in patients with sickle cell disease.
    Br J Haematol. 2025;206:919-923.
    

    >> Share

    
    February 2025
13. MAGGIO A, Napolitano M, Taher AT, Bou-Fakhredin R, et al
    Reframing thalassaemia syndrome as a benign haematopoietic stem cell disorder.
    Br J Haematol. 2025;206:464-477.
    

    >> Share

    
    
14. ZHANG J, Sun J, Huai W, Tang J, et al
    Elucidating loss-of-function mechanisms of monoallelic EPAS1 mutations underlying congenital hypoplastic anaemia in a paediatric anaemia cohort.
    Br J Haematol. 2025;206:585-595.
    

    >> Share

    
    
15. EL HOSS S, Bazoum H
    From old to new: Repurposed drugs in the battle towards curing sickle cell disease.
    Br J Haematol. 2025;206:795-797.
    

    >> Share

    
    
16. BHAT V, Potdar AA, Yu GK, Gibson G, et al
    Impact of hydroxycarbamide treatment on the whole-blood transcriptome in sickle cell disease.
    Br J Haematol. 2025;206:713-720.
    

    >> Share

    
    
17. GURNARI C, Visconte V
    Dissecting the genomic traits and clinical course of secondary myelodysplastic syndrome following aplastic anaemia: A milestone.
    Br J Haematol. 2025;206:790-791.
    

    >> Share

    
    
18. QI J, Wang T, Wang M, He P, et al
    Comparative study of the diversity of amino acids on human leucocyte antigen class II molecules in patients with acquired aplastic anaemia.
    Br J Haematol. 2025;206:735-748.
    

    >> Share

    
    
19. RAZ S, Koren A, Bogdanova AY, Gassmann M, et al
    Memantine treatment in sickle cell disease: A 1-year study of its effects on cognitive functions and neural processing.
    Br J Haematol. 2025;206:689-702.
    

    >> Share

    
    
20. SONGDEJ D, Teawtrakul N, Laoaroon N, Komvilaisak P, et al
    Impact of HbE mutation on the clinical severity of HbH disease: A multicentre study from Thailand.
    Br J Haematol. 2025;206:703-712.
    

    >> Share

    
    January 2025
21. GE S, Ali S, Haldane V, Bekdache C, et al
    An approach to Hemequity: Identifying the barriers and facilitators of iron deficiency reduction strategies in low- to middle-income countries.
    Br J Haematol. 2025 Jan 6. doi: 10.1111/bjh.19984.
    

    >> Share

    
    
22. KHAN AA, Laas CE, Brewin JN, Potter V, et al
    Development of a novel test of splenic function for use in a clinical diagnostic laboratory.
    Br J Haematol. 2025;206:320-330.
    

    >> Share

    
    
23. GEHRIE EA, Booth GS
    Contextualizing prophylactic red blood cell antigen matching in the lifelong care of sickle cell disease and thalassaemia patients.
    Br J Haematol. 2025;206:382-384.
    

    >> Share

    
    
24. GALADANCI NA, Kanter J
    Avascular necrosis in sickle cell disease needs more definitive treatment options.
    Br J Haematol. 2025;206:385-386.
    

    >> Share

    
    
25. PIECHNIK SK, Polzella P, Shah A, Vera-Aviles M, et al
    Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency.
    Br J Haematol. 2025;206:349-352.
    

    >> Share

    
    
26. NOGUER M, Berthon P, Makowski C, Messonnier LA, et al
    Impaired physical ability in patients with transfusion-dependent beta-thalassaemia: Can regular physical activity be a countermeasure?
    Br J Haematol. 2025;206:86-93.
    

    >> Share

    
    
27. WOLF J, Blais-Normandin I, Bathla A, Keshavarz H, et al
    Red cell specifications for blood group matching in patients with haemoglobinopathies: An updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines.
    Br J Haematol. 2025;206:94-108.
    

    >> Share

    
    
28. KOCHHAR M, McGann PT
    Sickle cell disease in India: Not just a mild condition.
    Br J Haematol. 2025;206:380-381.
    

    >> Share

    
    
29. SETH T, Udupi S, Jain S, Bhatwadekar S, et al
    Burden of vaso-occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients.
    Br J Haematol. 2025;206:296-309.
    

    >> Share

    
    
30. CASALE M, Toro G, Porcelli F, Quota A, et al
    Long-term outcomes of avascular necrosis in sickle cell disease using joint-specific patient-reported outcome measures: Results from a multicentre study.
    Br J Haematol. 2025;206:310-319.
    

    >> Share

    
    December 2024
31. LOTH G, Dumke CCK, Muratori RR, Pelegrina PD, et al
    Haematopoietic cell transplantation for 106 infants and preschoolers with acquired and inherited bone marrow failures.
    Br J Haematol. 2024;205:2387-2402.
    

    >> Share

    
    
32. SEGBEFIA CI, Smart LR, Stuber SE, Amissah-Arthur KN, et al
    Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa.
    Br J Haematol. 2024;205:2470-2480.
    

    >> Share

    
    November 2024
33. COSTA S, Minucci A, Kumawat A, De Bonis M, et al
    Pathogenic G6PD variants: Different clinical pictures arise from different missense mutations in the same codon.
    Br J Haematol. 2024;205:1985-1994.
    

    >> Share

    
    
34. CINTHO OZAHATA M, Guo Y, Gomes I, Malta B, et al
    Genetic variants associated with white blood cell count amongst individuals with sickle cell disease.
    Br J Haematol. 2024;205:1974-1984.
    

    >> Share

    
    
35. ELSHERIF L, Tang Y, Patillo KL, Wichlan D, et al
    Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia.
    Br J Haematol. 2024;205:1963-1973.
    

    >> Share

    
    
36. GURNARI C, Lima ACM, Pagliuca S
    HLA-lacking clones in aplastic anaemia: Adaptive or maladaptive?
    Br J Haematol. 2024;205:1681-1682.
    

    >> Share

    
    
37. MARIN V, Huguenin Y, Bessi L, Weinmann L, et al
    Beta-thalassaemia intermedia due to a complex alpha-globin rearrangement and a heterozygous beta thalassaemia mutation.
    Br J Haematol. 2024;205:1959-1962.
    

    >> Share

    
    
38. ZAIMOKU Y, Sakai K, Tsuji N, Hosomichi K, et al
    Haematopoietic regeneration by HLA-A*0206-deficient clones in severe aplastic anaemia without definitive immunosuppressive treatment.
    Br J Haematol. 2024;205:1995-1999.
    

    >> Share

    
    October 2024
39. GUPTA CL, Jaganathasamy N, Madkaikar M
    Microbiome in sickle cell disease: Pathophysiology and therapeutic insights.
    Br J Haematol. 2024;205:1279-1287.
    

    >> Share

    
    
40. GILTON M, Fernandes H, Martinez C, Leverger G, et al
    Association of paediatric autoimmune cytopenia and inflammatory bowel disease suggests a common genetic origin.
    Br J Haematol. 2024;205:1508-1515.
    

    >> Share

    
    
41. VALENTINI CG, Teofili L, Gehrie E
    Iron metabolism in sickle cell disease patients undergoing chronic red blood cell exchange: A delicate homeostasis in balance.
    Br J Haematol. 2024;205:1257-1259.
    

    >> Share

    
    
42. CONNES P, Nader E
    Could oxygen gradient ektacytometry help to detect sickle cell trait carriers at risk for kidney disorders or exercise-related complications?
    Br J Haematol. 2024;205:1260-1261.
    

    >> Share

    
    
43. RAMSAY Z, Ali A, Grant J, Asnani M, et al
    Exploring the role of viscosity-vaso-occlusion and haemolysis-endothelial dysfunction in pain sensitization among Jamaicans with sickle cell disease.
    Br J Haematol. 2024;205:1570-1580.
    

    >> Share

    
    
44. M ROSS J, Forte S, Mercure-Corriveau N, Lemay AS, et al
    Automated red blood cell exchange with a post-procedure haematocrit targeted at 34% in the chronic management of sickle cell disease.
    Br J Haematol. 2024;205:1556-1564.
    

    >> Share

    
    
45. ELLSWORTH P, Pawlinski IJ, Sielaty R, Ilich A, et al
    Hypertonicity and/or acidosis induce marked rheological changes under hypoxic conditions in sickle trait red blood cells.
    Br J Haematol. 2024;205:1565-1569.
    

    >> Share

    
    
46. KATO S, Chagi K, Takagi Y, Hidaka M, et al
    Machine/deep learning-assisted hemoglobin level prediction using palpebral conjunctival images.
    Br J Haematol. 2024;205:1590-1598.
    

    >> Share

    
    
47. LEE JM, Kim HS, Yoo J, Lee J, et al
    Genomic insights into inherited bone marrow failure syndromes in a Korean population.
    Br J Haematol. 2024;205:1581-1589.
    

    >> Share

    
    September 2024
48. CATELLA J, Turpin E, Connes P, Nader E, et al
    Impaired microvascular function in patients with sickle cell anemia and leg ulcers improved with healing.
    Br J Haematol. 2024 Sep 24. doi: 10.1111/bjh.19785.
    

    >> Share

    
    
49. STRAUSS JD, Brown DW, Zhou W, Dagnall C, et al
    Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.
    Br J Haematol. 2024;205:1180-1187.
    

    >> Share

    
    
50. PRABAHRAN A, Durrani J, Coelho-Da Silva J, Shalhoub R, et al
    Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia.
    Br J Haematol. 2024;205:1170-1179.
    

    >> Share

    
    
51. ZHOU LY, Derebail VK, Desai PC, Elsherif L, et al
    Persistent albuminuria and chronic kidney disease in adults with sickle cell anaemia: Results from a multicenter natural history study.
    Br J Haematol. 2024;205:1159-1169.
    

    >> Share

    
    
52. SADAF A, Dong M, Pfeiffer A, Korpik J, et al
    A pharmacokinetic-pharmacodynamic analysis of l-glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapy.
    Br J Haematol. 2024;205:1147-1158.
    

    >> Share

    
    
53. NKOY AB, Mumaka FM, Ngonde A, Mafumba SK, et al
    Relevance of repeated analyses of albuminuria and glomerular filtration rate in African children with sickle cell anaemia.
    Br J Haematol. 2024;205:1137-1146.
    

    >> Share

    
    
54. ZHOU X, Wagner V, Scheller L, Stanojkovska E, et al
    Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study.
    Br J Haematol. 2024;205:999-1010.
    

    >> Share

    
    August 2024
55. GLENTHOJ A, Grace RF, Lander C, van Beers EJ, et al
    Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry.
    Br J Haematol. 2024;205:613-623.
    

    >> Share

    
    
56. KATZ BZ, Karny S
    Pursuing the elusive footsteps of malaria in peripheral blood smears utilizing artificial intelligence.
    Br J Haematol. 2024;205:414-415.
    

    >> Share

    
    
57. SHARMA A, Kumar A, Rawat K, Vij S, et al
    Novel TMPRSS6 variants and their impact on iron-refractory iron deficiency anaemia in pregnancy: A North Indian genotype phenotype study.
    Br J Haematol. 2024;205:686-698.
    

    >> Share

    
    
58. RECH JS, Cohen A, Bartolucci P, Santin A, et al
    Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID-19 pandemic: A multicentre cohort study.
    Br J Haematol. 2024;205:463-472.
    

    >> Share

    
    
59. SEGBEFIA C, Luchtman-Jones L
    Seeing haemoglobin SC: Challenging the misperceptions.
    Br J Haematol. 2024;205:404-405.
    

    >> Share

    
    
60. NELSON M, Noisette L, Pugh N, Gordeuk V, et al
    The clinical spectrum of HbSC sickle cell disease-not a benign condition.
    Br J Haematol. 2024;205:653-663.
    

    >> Share

    
    
61. MOYSIS E, Brown BJ, Shokunbi W, Manescu P, et al
    Leveraging deep learning for detecting red blood cell morphological changes in blood films from children with severe malaria anaemia.
    Br J Haematol. 2024;205:699-710.
    

    >> Share

    
    
62. SHANDLEY LM, Fasano RM, Spencer JB, Mertens AC, et al
    The impact of sickle cell disease and its treatment on ovarian reserve in reproductive-aged Black women.
    Br J Haematol. 2024;205:674-685.
    

    >> Share

    
    
63. ROSSI M, Belinga S, Tolo A, Diop S, et al
    Determinants of the haemoglobin level in patients with sickle cell disease living in sub-Saharan Africa: Major impact of the country of residence and independent effects of leucocyte and platelet counts and haemolysis.
    Br J Haematol. 2024;205:664-673.
    

    >> Share

    
    
64. PIOLATTO A, Gaglioti CM, Tesio N, Clemente MG, et al
    Deferasirox film-coated tablet-associated ulcerative colitis: An emerging pattern in thalassemia patients?
    Br J Haematol. 2024;205:719-721.
    

    >> Share

    
    
65. HAN J, Zhang X, Shah BN, Saraf SL, et al
    Alkaline phosphatase as a marker for painful vaso-occlusive events and other acute complications in sickle cell disease.
    Br J Haematol. 2024;205:716-718.
    

    >> Share

    
    July 2024
66. CATELLA J, Guillot N, Nader E, Skinner S, et al
    Controversies in the pathophysiology of leg ulcers in sickle cell disease.
    Br J Haematol. 2024;205:61-70.
    

    >> Share

    
    
67. GOK V, Leblebisatan G, Gurlek Gokcebay D, Guler S, et al
    Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants.
    Br J Haematol. 2024;205:236-242.
    

    >> Share

    
    
68. CHEMINET G, Corbasson A, Charmettan M, Namaoui W, et al
    Assessment of fatigue in adult patients with sickle cell disease: Use of the functional assessment of chronic illness therapy-Fatigue (FACIT-fatigue) questionnaire.
    Br J Haematol. 2024;205:335-342.
    

    >> Share

    
    
69. MAYRAND L, Elie J, Pinhas Y, Rignault-Bricard R, et al
    Sputum interleukin-6 level as a marker of severity during acute chest syndrome in children with sickle cell disease.
    Br J Haematol. 2024;205:329-334.
    

    >> Share

    
    
70. PLAZA-FLORIDO A, Liem RI, Haddad F, Radom-Aizik S, et al
    Whole-blood transcriptome analysis reveals distinct gene expression signatures in paediatric patients with sickle cell anaemia before and after exercise.
    Br J Haematol. 2024;205:320-328.
    

    >> Share

    
    
71. ZHANG L, Chang M, Liu C, Xu Y, et al
    A case of de novo -alpha(3.7) thalassaemia and the utility of CATSA for detecting de novo mutations in thalassaemia.
    Br J Haematol. 2024;205:360-363.
    

    >> Share

    
    
72. PADENIYA P, Premawardhena A
    Obesity, liver steatosis and metabolic syndrome: The hidden enemies in transfusion-dependent thalassaemia.
    Br J Haematol. 2024;205:28-29.
    

    >> Share

    
    
73. RUIZ MA, Zhang X, Mansilla MA, Zahr RS, et al
    Prevalence of kidney health genetic variants in adults with sickle cell nephropathy.
    Br J Haematol. 2024;205:316-319.
    

    >> Share

    
    
74. KIM DH, Hong J, Shin DY, Kim I, et al
    Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Br J Haematol. 2024;205:356-359.
    

    >> Share

    
    
75. HANDS K, Daru J, Evans C, Kotze A, et al
    Identification and management of preoperative anaemia in adults: A British Society for Haematology Guideline update.
    Br J Haematol. 2024;205:88-99.
    

    >> Share

    
    June 2024
76. GUARNERA L, Visconte V
    The metabolic fuel of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2024;204:2162-2164.
    

    >> Share

    
    
77. SHAH FT, Nicolle S, Garg M, Pancham S, et al
    Guideline for the management of conception and pregnancy in thalassaemia syndromes: A British Society for Haematology Guideline.
    Br J Haematol. 2024;204:2194-2209.
    

    >> Share

    
    
78. RICCHI P, Pistoia L, Positano V, Spasiano A, et al
    Liver steatosis in patients with transfusion-dependent thalassaemia.
    Br J Haematol. 2024;204:2458-2467.
    

    >> Share

    
    
79. ZACCHEDDU E, Zappu A, Barella S, Clemente MG, et al
    Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept.
    Br J Haematol. 2024;204:2505-2507.
    

    >> Share

    
    
80. CHEN Y, Liu H, Wang C, Chen W, et al
    The histone demethylase JMJD1C regulates CPS1 expression and promotes the proliferation of paroxysmal nocturnal haemoglobinuria clones through cell metabolic reprogramming.
    Br J Haematol. 2024;204:2468-2479.
    

    >> Share

    
    
81. DAVILA J, O'Brien SH, Mitchell WB, Manwani D, et al
    Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap.
    Br J Haematol. 2024;204:2184-2193.
    

    >> Share

    
    May 2024
82. PHONGPAO K, Pholngam N, Chokchaichamnankit D, Nuamsee K, et al
    Proteomic profiling of circulating beta-thalassaemia/haemoglobin E extra-cellular vesicles reveals that association with immunoglobulin induces membrane vesiculation.
    Br J Haematol. 2024;204:2025-2039.
    

    >> Share

    
    
83. CASABIANCA M, Gauthier A, Nader E, Cannas G, et al
    Red blood cell senescence and vascular function in patients with hereditary spherocytosis with and without splenectomy.
    Br J Haematol. 2024;204:e41-e44.
    

    >> Share

    
    
84. HAGRY J, Monnet X, Mekontso-Dessap A, Chantalat C, et al
    Comprehensive assessment, pain and ventilatory management during acute complications of adult sickle cell disease: A clinical practice survey in French intensive care units.
    Br J Haematol. 2024;204:e37-e40.
    

    >> Share

    
    
85. MANARA R, Brotto D, Barillari MR, Costa G, et al
    Hearing loss in beta-thalassaemia: An Italian multicentre case-control study.
    Br J Haematol. 2024;204:2016-2024.
    

    >> Share

    
    
86. LIPTON JM
    Understanding complex disease-related mechanisms: Rational therapies for Diamond-Blackfan anaemia.
    Br J Haematol. 2024;204:1598-1599.
    

    >> Share

    
    
87. TOMBUL Z, Bahaj W, Ozturk M, Patel B, et al
    Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2024;204:2121-2124.
    

    >> Share

    
    
88. ROGER G, Denormandie P, Gobe T, Azzolina D, et al
    Left ventricular global longitudinal strain and acute myocardial injury in patients with sickle cell disease admitted to the intensive care unit for vaso-occlusive crisis.
    Br J Haematol. 2024;204:2007-2015.
    

    >> Share

    
    
89. DUNCAN BB, Lotter JL, Superata J, Barranta ME, et al
    Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag.
    Br J Haematol. 2024;204:2077-2085.
    

    >> Share

    
    
90. BIANCHI C, Margot H, Fernandes H, Pasquet M, et al
    Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients.
    Br J Haematol. 2024;204:1899-1907.
    

    >> Share

    
    
91. UKONMAANAHO EM, Dell'Anna S, Hakonen A, Wartiovaara-Kautto U, et al
    Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review.
    Br J Haematol. 2024;204:2040-2048.
    

    >> Share

    
    
92. GIORGETTI A, Nyilima S, Stoffel NU, Moretti D, et al
    Stable iron ((58)Fe) isotopic measurements in Kenyan toddlers during 3 months of iron supplementation demonstrate that half of the iron absorbed is lost.
    Br J Haematol. 2024;204:2057-2065.
    

    >> Share

    
    
93. MAEDA T, Matsuda A, Kanda J, Kawabata H, et al
    Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.
    Br J Haematol. 2024;204:2086-2096.
    

    >> Share

    
    
94. NEYER PJ, Kabore B, Nakas CT, Diallo S, et al
    Increased erythroferrone levels in malarial anaemia.
    Br J Haematol. 2024;204:2066-2070.
    

    >> Share

    
    April 2024
95. ARCANJO GS, Souza MB, Domingos IF, Pereira-Martins DA, et al
    BMP6 and VDR gene polymorphisms are associated with osteonecrosis in a sickle cell anaemia cohort.
    Br J Haematol. 2024;204:1507-1514.
    

    >> Share

    
    
96. CHANG A, Wilson SR, Morris S, Wichlan D, et al
    Nocturnal hypoxaemia is common in adults with sickle cell anaemia.
    Br J Haematol. 2024;204:1495-1499.
    

    >> Share

    
    
97. JACOBS JW, Sharma D, Stephens LD, Figueroa Villalba CA, et al
    Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review.
    Br J Haematol. 2024;204:1500-1506.
    

    >> Share

    
    
98. KUNVARJEE B, Contreras Yametti GP, Blouin AG, Linder GE, et al
    Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report.
    Br J Haematol. 2024;204:1540-1544.
    

    >> Share

    
    March 2024
99. EBEA-UGWUANYI PO, Vidyasagar S, Connor JR, Frazer DM, et al
    Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomes.
    Br J Haematol. 2024;204:759-773.
    

    >> Share

    
    
100. KULASEKARARAJ A, Cavenagh J, Dokal I, Foukaneli T, et al
     Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.
     Br J Haematol. 2024;204:784-804.
     

     >> Share

     
     
101. LEE GM, Batchvarova M, Delahunty M, Boateng L, et al
     Sickle red blood cells directly activate neutrophils.
     Br J Haematol. 2024;204:e28-e30.
     

     >> Share

     
     
102. JONASSAINT CR, Parchuri E, O'Brien JA, Lalama CM, et al
     Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.
     Br J Haematol. 2024;204:1029-1038.
     

     >> Share

     
     
103. HANSEN DL, Maquet J, Lafaurie M, Moller S, et al
     Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France.
     Br J Haematol. 2024;204:1072-1081.
     

     >> Share

     
     
104. EARLY ML, Raja M, Luo A, Solow M, et al
     Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease.
     Br J Haematol. 2024;204:1039-1046.
     

     >> Share

     
     
105. KISALI EP, Iversen PO, Makani J
     Low vitamin B(12) blood levels in sickle cell disease: Data from a large cohort study in Tanzania.
     Br J Haematol. 2024;204:1047-1053.
     

     >> Share

     
     
106. STEINBERG-SHEMER O, Yacobovich J, Noy-Lotan S, Dgany O, et al
     Biallelic hypomorphic variants in CAD cause uridine-responsive macrocytic anaemia with elevated haemoglobin-A2.
     Br J Haematol. 2024;204:1067-1071.
     

     >> Share

     
     
107. LIU H, Ding K, Zhang W, Xing L, et al
     A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
     Br J Haematol. 2024;204:1082-1085.
     

     >> Share

     
     
108. MUNARETTO V, Corti P, Bertoni E, Tripodi SI, et al
     Acute chest syndrome in children with sickle cell disease: Data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system.
     Br J Haematol. 2024;204:1061-1066.
     

     >> Share

     
     February 2024
109. WARE RE, Quinn CT
     The bold promise of gene therapy for sickle cell disease.
     Br J Haematol. 2024;204:381-382.
     

     >> Share

     
     
110. STEENSMA DP
     Revisiting the first reported case of aplastic anaemia.
     Br J Haematol. 2024;204:455-458.
     

     >> Share

     
     
111. KATAGIRI T, Iwasaki H, Fujieda A, Kasashima S, et al
     A case of hepatitis-associated aplastic anaemia following living-donor liver transplantation for fulminant hepatitis showing loss of heterozygosity in the 6p chromosome in the affected liver.
     Br J Haematol. 2024;204:623-627.
     

     >> Share

     
     
112. HUNT RC, Kimchi-Sarfaty C
     A synonymous variant is unmasked in thalassaemia.
     Br J Haematol. 2024;204:399-401.
     

     >> Share

     
     
113. KHWAJA J, Japzon N, Gabriel M, Raju K, et al
     Cold agglutinin disease and cryoglobulinaemia: A frequent coexistence with clinical impact.
     Br J Haematol. 2024;204:e21-e24.
     

     >> Share

     
     
114. EARLY ML, Luo A, Solow M, Matusiak K, et al
     Natural history of blood pressure in sickle cell disease pregnancy.
     Br J Haematol. 2024;204:658-667.
     

     >> Share

     
     
115. CHAKRAVORTY S, Drasar E, Kaya B, Kesse-Adu R, et al
     UK Haemoglobin Disorders Peer Review: A Quality Standards-based review programme for sickle cell disease and thalassaemia.
     Br J Haematol. 2024;204:668-676.
     

     >> Share

     
     
116. SISLER I, McClish DK, Villella A, Valrie C, et al
     Impact of community health workers on quality of life in adolescents and young adults with sickle cell disease: The SHIP-HU study.
     Br J Haematol. 2024;204:649-657.
     

     >> Share

     
     
117. GORIVALE M, Sawant P, Kargutkar N, Hariharan P, et al
     When a synonymous mutation breaks the silence in a thalassaemia patient.
     Br J Haematol. 2024;204:677-682.
     

     >> Share

     
     January 2024
118. OYARBIDE U, Crane GM, Corey SJ
     The metabolic basis of inherited neutropenias.
     Br J Haematol. 2024;204:45-55.
     

     >> Share

     
     
119. PETERS C
     Haematopoietic stem cell transplantation in children with sickle cell disease: Still to do?
     Br J Haematol. 2024;204:22-23.
     

     >> Share

     
     
120. DANIEL Y, Henthorn J
     Lessons learnt in the screening and diagnosis of haemoglobinopathies.
     Br J Haematol. 2024;204:68-73.
     

     >> Share

     
     
121. SHOOK LM, Ware RE
     Screening for haemoglobin disorders: One size may not fit all.
     Br J Haematol. 2024;204:26-28.
     

     >> Share

     
     
122. CSEH A, Galimard JE, de la Fuente J, Isgro A, et al
     Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties.
     Br J Haematol. 2024;204:e1-e5.
     

     >> Share

     
     
123. GUINDO A, Cisse Z, Keita I, Desmonde S, et al
     Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan(R) and HemotypeSC(R)) on cord blood.
     Br J Haematol. 2024;204:337-345.
     

     >> Share

     
     
124. ALLALI S, Marquant F, Rignault-Bricard R, Taylor M, et al
     Oral famotidine reduces the plasma level of soluble P-selectin in children with sickle cell disease.
     Br J Haematol. 2024;204:346-351.
     

     >> Share

     
     December 2023
125. PIZZO A, Porter JS, Carroll Y, Burcheri A, et al
     Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators.
     Br J Haematol. 2023;203:712-721.
     

     >> Share

     
     
126. MISHKIN AD, Prince EJ, Leimbach EJ, Mapara MY, et al
     Psychiatric comorbidities in adults with sickle cell disease: A narrative review.
     Br J Haematol. 2023;203:747-759.
     

     >> Share

     
     November 2023
127. GREEN NS, Rosano C, Bangirana P, Opoka R, et al
     Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia.
     Br J Haematol. 2023;203:460-467.
     

     >> Share

     
     
128. BANDINI P, Borras N, Fernandez Mellid E, Martin-Fernandez L, et al
     First description of bone marrow failure syndrome in Spain caused by mutations in the ERCC6L2 gene.
     Br J Haematol. 2023;203:e102-e107.
     

     >> Share

     
     
129. STEWART GW, Gibson JS, Rees DC
     The cation-leaky hereditary stomatocytosis syndromes: A tale of six proteins.
     Br J Haematol. 2023;203:509-522.
     

     >> Share

     
     
130. NOVAK W, Berner J, Svaton M, Jimenez-Heredia R, et al
     Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3.
     Br J Haematol. 2023;203:678-683.
     

     >> Share

     
     
131. SCULLY M, Rayment R, Clark A, Westwood JP, et al
     A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.
     Br J Haematol. 2023;203:546-563.
     

     >> Share

     
     
132. FERMO E, Zaninoni A, Vercellati C, Marcello AP, et al
     When alpha spectrin null alleles meet low expression alpha spectrin polymorphisms.
     Br J Haematol. 2023;203:684-687.
     

     >> Share

     
     October 2023
133. ALADJIDI N, Pincez T, Rieux-Laucat F, Nugent D, et al
     Paediatric-onset Evans syndrome: Breaking away from refractory immune thrombocytopenia.
     Br J Haematol. 2023;203:28-35.
     

     >> Share

     
     
134. RANQUE B, Diaw M, Dembele AK, Lapoumeroulie C, et al
     Association of haemolysis markers, blood viscosity and microcirculation function with organ damage in sickle cell disease in sub-Saharan Africa (the BIOCADRE study).
     Br J Haematol. 2023;203:319-326.
     

     >> Share

     
     
135. ALSULTAN A, Abujoub R, Alsudairy R, Memon S, et al
     Human leucocyte antigen-matched related haematopoietic stem cell transplantation using low-dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia.
     Br J Haematol. 2023;203:255-263.
     

     >> Share

     
     
136. HEBBEL RP, Milbauer L, Wei P
     A novel promoter of endothelial dysfunction in African Americans: Relevance to sickle cell anaemia.
     Br J Haematol. 2023;203:e71-e73.
     

     >> Share

     
     September 2023
137. ZHANG Y, Xie H, Liang G, Qin Y, et al
     A novel gain-of-function PIP4K2A mutation elevates the expression of beta-globin and aggravates the severity of alpha-thalassemia.
     Br J Haematol. 2023;202:1018-1023.
     

     >> Share

     
     
138. NANNELLI C, Bosman A, Cunningham J, Dugue PA, et al
     Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification.
     Br J Haematol. 2023;202:1024-1032.
     

     >> Share

     
     
139. DE ALCANTARA PEDRO PP, Castro CHM, Pinheiro MM, Goncalves LM, et al
     Vertebral fractures and low lean mass in young men with sickle cell disease: Lack of association with bone mineral density and clinical characteristics.
     Br J Haematol. 2023;202:e46-e49.
     

     >> Share

     
     
140. HAN J, Saraf SL, Gordeuk VR
     Vaccination in sickle cell disease: Immunocompromised or immunocompetent?
     Br J Haematol. 2023;202:916-918.
     

     >> Share

     
     
141. ESPERTI S, Nader E, Boisson C, Carin R, et al
     Mitochondria retention in mature RBCs from haemoglobin SC patients.
     Br J Haematol. 2023;202:e36-e38.
     

     >> Share

     
     
142. KNIGHT-MADDEN J, King L, Asnani M, Skyers N, et al
     Needs assessment in adults and parents of children living with sickle cell disease in Jamaica.
     Br J Haematol. 2023;202:e31-e35.
     

     >> Share

     
     
143. NAKAHARA H, Cheedarla N, Verkerke HP, Cheedarla S, et al
     Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.
     Br J Haematol. 2023;202:937-941.
     

     >> Share

     
     
144. GUPTA A, Gooda R, Marouf R
     Pseudo-Gaucher cells in a splenectomised Beta-Thalassemia patient.
     Br J Haematol. 2023;202:911.
     

     >> Share

     
     
145. ZOLLER H, Wagner S, Schaefer B
     What is wrong in doing good?
     Br J Haematol. 2023;202:1089-1090.
     

     >> Share

     
     
146. ASHER S, Shah R, Ings S, Horder J, et al
     Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.
     Br J Haematol. 2023;202:1224-1227.
     

     >> Share

     
     
147. DASARI S, Tse W, Wang J
     Real-world evidence of incidence and outcomes of aplastic anaemia following administration of immune checkpoint inhibitors.
     Br J Haematol. 2023;202:1205-1208.
     

     >> Share

     
     
148. CHU Z, Cushway T, Wong M, Lim KX, et al
     Incidence and predictors of hypophosphataemia after ferric carboxymaltose use-A 3-year experience from a single institution in Singapore.
     Br J Haematol. 2023;202:1199-1204.
     

     >> Share

     
     
149. MANGANAS K, Delicou S, Xydaki A, Kourakli A, et al
     Predisposing factors for advanced liver fibrosis in patients with sickle cell disease.
     Br J Haematol. 2023;202:1192-1198.
     

     >> Share

     
     
150. JACOBS JW, Ding JJ, Tormey CA, Abels EA, et al
     Where do they go? The clinical conundrum of warm autoantibodies and their inability to cause haemolytic disease of the foetus and newborn.
     Br J Haematol. 2023;202:1213-1215.
     

     >> Share

     
     August 2023
151. ELSHERIF L, Kanthakumar P, Afolabi J, Stratton AF, et al
     Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemia.
     Br J Haematol. 2023;202:669-673.
     

     >> Share

     
     
152. GIBSON JS, Stewart GW
     A critical role for altered red cell cation permeability in pathogenesis of sickle cell disease and other haemolytic anaemias.
     Br J Haematol. 2023;202:462-464.
     

     >> Share

     
     
153. NADER E, Conran N, Leonardo FC, Hatem A, et al
     Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium-dependent manner.
     Br J Haematol. 2023;202:657-668.
     

     >> Share

     
     
154. HAMANI S, Lioure B, Nicolae A, Lipsker D, et al
     A Rare Cause of Refractory Anaemia hidden between Folds.
     Br J Haematol. 2023;202:712.
     

     >> Share

     
     
155. JOLY P, Nader E, Ketels F, Boisson C, et al
     Effects of pyruvate kinase activators on red blood cell properties in sickle cell disease.
     Br J Haematol. 2023;202:e27-e30.
     

     >> Share

     
     
156. ZHANG X, Han J, Shah BN, Saraf SL, et al
     Platelet count decline and high neutrophil count within the first day of admission for painful sickle cell vaso-occlusive episodes predict severe complications.
     Br J Haematol. 2023;202:e20-e23.
     

     >> Share

     
     
157. MARTIN OY, Margulies S, Speller-Brown B, Majumdar S, et al
     The evolution of the COVID-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron.
     Br J Haematol. 2023;202:479-484.
     

     >> Share

     
     July 2023
158. RAI MP, Lee EJ, Bussel JB
     Maintenence rituximab following induction in autoimmune cytopenias.
     Br J Haematol. 2023;202:153-158.
     

     >> Share

     
     
159. HAROUN E, Dutta D, Lim SH
     Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell disease.
     Br J Haematol. 2023;202:184-194.
     

     >> Share

     
     
160. FERRONE FA
     More of the same? Voxelotor spawns a successor, but on what success does it build?
     Br J Haematol. 2023;202:13-15.
     

     >> Share

     
     
161. DUFU K, Alt C, Strutt S, Partridge J, et al
     GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.
     Br J Haematol. 2023;202:173-183.
     

     >> Share

     
     June 2023
162. SHETH S, Taher AT, Coates TD, Kattamis A, et al
     Management of luspatercept therapy in patients with transfusion-dependent beta-thalassaemia.
     Br J Haematol. 2023;201:824-831.
     

     >> Share

     
     
163. WU J, Wang J, Tang N, Wang X, et al
     An atypical patient with bone marrow failure syndrome-2 without microcephaly and learning disability in a Chinese family.
     Br J Haematol. 2023;201:e50-e53.
     

     >> Share

     
     
164. LIN Y, Del Giudice ME, Kron A, Meirovich H, et al
     A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia.
     Br J Haematol. 2023;201:1000-1004.
     

     >> Share

     
     
165. PENG Y, Liang L, Zhang H, Liu H, et al
     Single-cell profiling of ineffective erythropoiesis in a mouse model of beta-thalassaemia intermedia.
     Br J Haematol. 2023;201:982-994.
     

     >> Share

     
     
166. BAIN BJ, Daniel Y, Henthorn J, de la Salle B, et al
     Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
     Br J Haematol. 2023;201:1047-1065.
     

     >> Share

     
     
167. JACOBS JW, Stephens LD, Allen ES, Binns TC, et al
     Epidemiological and clinical features, therapeutic strategies and outcomes in patients with hyperhaemolysis: A systematic review.
     Br J Haematol. 2023;201:1025-1032.
     

     >> Share

     
     
168. GENDREAU S, Cecchini J, Perier F, Razazi K, et al
     Effect of high-flow oxygen therapy on regional oxygen saturation during vaso-occlusive pain crisis: An observational study.
     Br J Haematol. 2023;201:e58-e61.
     

     >> Share

     
     
169. TAKASAKI K, Friedman DF, Uter S, Vege S, et al
     Variant RHD alleles and Rh immunization in patients with sickle cell disease.
     Br J Haematol. 2023;201:1220-1228.
     

     >> Share

     
     
170. LI J, Wang Y, Zhang Y, Zhang X, et al
     Haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia and non-hepatitis-associated aplastic anaemia: A propensity score-matched analysis.
     Br J Haematol. 2023;201:1179-1191.
     

     >> Share

     
     
171. CHEMINET G, Brunetti A, Khimoud D, Ranque B, et al
     Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admission.
     Br J Haematol. 2023;201:1229-1238.
     

     >> Share

     
     
172. JARISCH A, Salzmann-Manrique E, Soerensen J, Sach G, et al
     Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
     Br J Haematol. 2023;201:1159-1168.
     

     >> Share

     
     May 2023
173. GAVILLET M, Rufer N, Grandoni F, Rizzi M, et al
     Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report.
     Br J Haematol. 2023;201:581-584.
     

     >> Share

     
     
174. PICCIN A, Magzoub I, Hervig T
     The 'scintilla' starting vaso-occlusion in sickle cell disease.
     Br J Haematol. 2023;201:379-380.
     

     >> Share

     
     
175. AN R, Man Y, Cheng K, Zhang T, et al
     Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor.
     Br J Haematol. 2023;201:552-563.
     

     >> Share

     
     
176. TOWERMAN AS, Guilliams KP, Guerriero R, Shinawi MS, et al
     Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease.
     Br J Haematol. 2023;201:e30-e33.
     

     >> Share

     
     
177. LUNATI-ROZIE A, Janin A, Faubert E, Nony S, et al
     Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the ANK1 gene: Report of two cases of hereditary spherocytosis.
     Br J Haematol. 2023;201:e46-e49.
     

     >> Share

     
     
178. TENNENBAUM J, Volle G, Pouchot J, Joseph L, et al
     Increased risk of venous thromboembolism in splenectomized patients with sickle cell disease.
     Br J Haematol. 2023;201:793-796.
     

     >> Share

     
     April 2023
179. SICA M, Barone F, Nannelli C, Ricci P, et al
     The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab.
     Br J Haematol. 2023;201:e1-e4.
     

     >> Share

     
     
180. KAPUR R
     The potential of metabolomics as a predictive guide for clinical management in autoimmunity against red blood cells.
     Br J Haematol. 2023;201:13-14.
     

     >> Share

     
     
181. ROSSI M, Pirenne F, Le Roux E, Smaine D, et al
     Delayed haemolytic transfusion reaction in paediatric patients with sickle cell disease: A retrospective study in a French national reference centre.
     Br J Haematol. 2023;201:125-132.
     

     >> Share

     
     
182. WANG YM, Loveless M, Miller E, Nelson AS, et al
     Phenotypes of adults with Fanconi anaemia.
     Br J Haematol. 2023;201:133-139.
     

     >> Share

     
     
183. RABELO IB, Chiba AK, Moritz E, D'Amora P, et al
     Metabolomic profile in patients with primary warm autoimmune haemolytic anaemia.
     Br J Haematol. 2023;201:140-149.
     

     >> Share

     
     
184. JACOB M, Kawadler JM, Murdoch R, Ahmed M, et al
     Brain volume in Tanzanian children with sickle cell anaemia: A neuroimaging study.
     Br J Haematol. 2023;201:114-124.
     

     >> Share

     
     
185. KOREN A
     The continuing global challenges of treating patients with beta-thalassemia.
     Br J Haematol. 2023;201:183-184.
     

     >> Share

     
     
186. JACOBS JW, Binns TC, Abels E, Tormey CA, et al
     Autoimmune haemolytic anaemia secondary to babesiosis: A review of reported cases and description of a novel association with cold antibody-mediated haemolytic anaemia.
     Br J Haematol. 2023;201:364-369.
     

     >> Share

     
     
187. SUTRA DEL GALY A, Willems L, D'Aveni M, Pautas C, et al
     Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
     Br J Haematol. 2023;201:e16-e20.
     

     >> Share

     
     
188. HOKLAND P, Daar S, Khair W, Sheth S, et al
     Thalassaemia-A global view.
     Br J Haematol. 2023;201:199-214.
     

     >> Share

     
     
189. DONZE C, Benoit A, Thuret I, Faust C, et al
     beta-Thalassemia in childhood: Current state of health in a high-income country.
     Br J Haematol. 2023;201:334-342.
     

     >> Share

     
     
190. EARLEY EJ, Kelly S, Fang F, Alencar CS, et al
     Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.
     Br J Haematol. 2023;201:343-352.
     

     >> Share

     
     
191. JACOBS JW, Booth GS, Guarente J, Schlafer D, et al
     Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
     Br J Haematol. 2023;201:227-233.
     

     >> Share

     
     March 2023
192. TSITSIKAS DA, Rowe S, Bosch A, Hui C, et al
     Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease.
     Br J Haematol. 2023;200:e50-e52.
     

     >> Share

     
     
193. MCKEAGUE S, Peake N, Lovelock D, Chow J, et al
     Acquired HbH disease diagnosed by HbA1c capillary electrophoresis.
     Br J Haematol. 2023;200:687.
     

     >> Share

     
     
194. KOEHL B, Claude L, Reminy K, Tarer V, et al
     Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle cell trait.
     Br J Haematol. 2023;200:812-820.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share